IMUGENE CHART. TA only, page-31081

ive been so impressed with the consolidstion and stability of the share price, but agree we are ready to turn higher.

the assets are still being well under valued and Dr Nick Ede highlighted so directly in the last preso , that specifically , Amgen , are watching closely , very closely.

all we need is a sniff of good results and clarity that the drug combo is working and look out.

Blincyto is already a blockbuster in 10% of cancers doing 10bill USD sales p.a

if we were able to give them some line of sight of potentially opening up the other 90% then IMU will rocket to the stratosphere

$1 should be on your radar if OncARlytics is the goods.

remember , this is the creation of the genius Yuman Fong and in him i believe.